Bayer: Observational study closed enrollment, 529 enrolled (Chronic Kidney Disease, Type 2 Diabetes Mellitus)
Bayer: Observational study closed enrollment, 529 enrolled (Chronic Kidney Disease, Type 2 Diabetes Mellitus). Its enrollment of 529 is top-decile (90th percentile of 8,879 records). Dated 28 days ago, it is in the active follow-up window. Score 60/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 529 · 90th percentile of 8,879 ClinicalTrialStartPulse records · 6.6x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Bayer |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea |
| NCT ID | NCT07232537 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Chronic Kidney Disease; Type 2 Diabetes Mellitus |
| Intervention types | drug |
| Target enrollment | 529 |
| Site countries | South Korea |
| Posted | 2025-11-18 |
| Planned start | 2025-11-20 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-08 |
| Last update posted | 2026-10-08 |
| enrollment percentile | 90th of 8,879 (median 80, 6.6x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Bayer
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Bayer + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-08
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Bayer and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Bayer's enrollment: 90th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
60 / 100 Score
- Industry sponsor (buys outsourced services).
- Enrollment closed: data management, monitoring and closeout ahead.
- 529 participants planned.
What is the ClinicalTrialStartPulse record for Bayer?
Bayer's Observational study (NCT07232537) in Chronic Kidney Disease, first posted 2025-11-18: enrollment closed (active, not recruiting) (2026-10-08), in an update posted 2026-10-08.
How does Bayer compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 529 is 6.6x the median of 80 across 8,879 records. It is 28 days old, still within a typical 45-day follow-up window.
Bayer vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Bayer | NONUS | 529 | 90th | 2026-10-08 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | NONUS | 366 | 85th | 2026-11-03 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
| Teva Branded Pharmaceutical Products R&D LLC | NONUS | 1,085 | 95th | 2026-11-03 |
Related records
- Calyxo, Inc.
- Hoffmann-La Roche
- Restor3D
- Kardium Inc.
- Janssen Biotech, Inc.
- Janssen Scientific Affairs, LLC
- Ethicon Endo-Surgery
- Janssen Pharmaceutica N.V., Belgium
- Janssen-Cilag International NV
- Janssen Biotech, Inc.
- Teva Branded Pharmaceutical Products R&D LLC
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Bayer and peer observational records
Get new ClinicalTrialStartPulse records like Bayer by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.